UPDATE : Monday, September 7, 2020
상단여백
Local drugmakers speed up NASH drug development
Domestic pharmaceutical companies are rushing to develop a treatment for no...
by Lee Hye-seon  |  2019-08-16 13:52
라인
Last trial OKed for Eylea to prevent blindness in premature infants
The Korean drug regulator has approved a phase-3 clinical trial on Eylea (i...
by Lee Hye-seon  |  2019-08-13 12:42
라인
Yuhan can continue testing lung cancer drug Lazertinib
Four deaths occurred during Yuhan Corp.’s clinical trial on new lung cancer...
by Lee Hye-seon  |  2019-08-12 12:58
라인
Drug regulator to enhance clinical trial management by 2023
The Ministry of Food and Drug Safety on Thursday announced a “Comprehensive...
by Lee Hye-seon  |  2019-08-08 14:55
라인
New weight loss drug Qsymia wins local approval
The local drug regulator has approved a new obesity treatment, Qsymia Cap. ...
by Lee Hye-seon  |  2019-08-01 10:57
라인
One in 45 Koreans prescribed with diet pills
One in 45 Koreans was prescribed with an appetite suppressant for obesity t...
by Lee Hye-seon  |  2019-07-30 15:44
라인
Rare Fabry disease depicted in K-dramas
Recent SBS drama “Doctor John” and MBC’s “Partners for Justice Season 2” us...
by Lee Hye-seon  |  2019-07-30 12:40
라인
Top-30 makers produce more than half of drugs
Drug output by 30 largest pharmaceutical companies accounted for 54 percent...
by Lee Hye-seon  |  2019-07-29 16:38
라인
Government employee stages one-person protest against own ministry
Kang Yoon-hee has been working as a committee member of the Clinical Trial ...
by Lee Hye-seon  |  2019-07-18 17:07
라인
Ministry extends data submission for cell therapy CureSkin
The drug regulator said it has granted S.Biomedics to extend the submission...
by Lee Hye-seon  |  2019-07-15 14:35
라인
Ministry to request investigation into Meditoxin approval process
The Ministry of Food and Drug Safety denied a suspicion that the ministry p...
by Lee Hye-seon  |  2019-07-12 16:29
라인
Acute renal failure reported in ibandronate injections
The government warned that ibandronate injections for the treatment of oste...
by Lee Hye-seon  |  2019-07-11 13:34
라인
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance
Pfizer Korea has failed to reduce the number of target participants in post...
by Lee Hye-seon  |  2019-07-08 16:39
라인
Kolon confident to resume US trial on Invossa
The government has decided to nullify Invossa-K’s license effective next Tu...
by Lee Hye-seon  |  2019-07-04 14:05
라인
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’
Kolon Life Science CEO said he would seek an administrative suit against th...
by Lee Hye-seon  |  2019-07-03 11:52
라인
26 new drugs approved in H1
Twenty-six new pharmaceutical products received approval in Korea in the fi...
by Lee Hye-seon  |  2019-07-02 14:31
라인
Multinationals face suspension of drug imports
The regulator ordered multinational pharmaceutical firms, including MSD Kor...
by Lee Hye-seon  |  2019-07-01 14:12
라인
Government to help cover costs for injuries from side effects
The government said it would help patients get compensation for diseases ca...
by Lee Hye-seon  |  2019-06-28 12:30
라인
Samsung Bioepis readies phase-3 trial on Soliris biosimilar
Samsung Bioepis is speeding up to develop a biosimilar of Soliris (eculizum...
by Lee Hye-seon  |  2019-06-27 17:14
라인
False ads of ‘hair loss treatments’ got caught
Korea’s drug regulator said it has found many advertisements that either pr...
by Lee Hye-seon  |  2019-06-27 16:42
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top